imdusiran (AB-729) / Arbutus  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
imdusiran (AB-729) / Arbutus
NCT06277037: Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

Not yet recruiting
N/A
35
Europe, US, RoW
Non-interventional
Arbutus Biopharma Corporation
Long Term Follow-up
08/29
10/29

Download Options